Last Updated:
Name Designation Appointment Date Status
Ishaan Pejavar Rao

Appointed as Director since October 2018

Director 24-Oct-2018 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Nandan Pejavar Rao

Appointed as Director since October 2018

Director 24-Oct-2018 Current
Nilima Dayanand Rao

Appointed as Managing Director since January 2017

Managing Director 24-Jan-2017 Current

People Timeline

Explore the timeline of key personnel in Remidex Pharma Private Limited's leadership journey.

Loading...
Contact Details
  • Address B-249,250,147&148, 6Th Main 2Nd Stage, Peenya Industrial Estate, Bengaluru Karnataka, 560058, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Remidex Pharma Private Limited?
You can contact Remidex Pharma Private Limited through their registered address at B-249,250,147&148, 6Th Main 2Nd Stage, Peenya Industrial Estate, Bengaluru Karnataka, 560058, India, or via their website at remidexpharma.com. Social media links are also provided where applicable.
Who are the current directors of Remidex Pharma Private Limited?
The current directors of Remidex Pharma Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • ISHAAN PEJAVAR RAO
  • NANDAN PEJAVAR RAO
  • NILIMA DAYANAND RAO
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available